BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34792571)

  • 1. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.
    Bazarbachi AH; Avet-Loiseau H; Szalat R; Samur AA; Hunter Z; Shammas M; Corre J; Fulciniti M; Anderson KC; Parmigiani G; Treon SP; Mohty M; Munshi NC; Samur MK
    Blood; 2021 Nov; 138(20):1980-1985. PubMed ID: 34792571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
    Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
    Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
    Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
    Konduri K; Sahota SS; Babbage G; Tong AW; Kumar P; Newman JT; Stone MJ
    Clin Lymphoma; 2005 Mar; 5(4):285-9. PubMed ID: 15794867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Belch AR; Pilarski LM
    Blood; 2004 Oct; 104(7):2134-42. PubMed ID: 14764523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
    Willenbacher W; Willenbacher E; Brunner A; Manzl C
    Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
    [No Abstract]   [Full Text] [Related]  

  • 7. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
    Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
    Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
    Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
    J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
    Xu L; Hunter ZR; Yang G; Zhou Y; Cao Y; Liu X; Morra E; Trojani A; Greco A; Arcaini L; Varettoni M; Brown JR; Tai YT; Anderson KC; Munshi NC; Patterson CJ; Manning RJ; Tripsas CK; Lindeman NI; Treon SP
    Blood; 2013 Mar; 121(11):2051-8. PubMed ID: 23321251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.
    Avet-Loiseau H; Garand R; Lodé L; Harousseau JL; Bataille R;
    Blood; 2003 Feb; 101(4):1570-1. PubMed ID: 12393502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.
    Jiménez C; Prieto-Conde MI; García-Álvarez M; Alcoceba M; Escalante F; Chillón MDC; García de Coca A; Balanzategui A; Cantalapiedra A; Aguilar C; Corral R; González-López T; Marín LA; Bárez A; Puig N; García-Mateo A; Gutiérrez NC; Sarasquete ME; González M; García-Sanz R
    Ann Hematol; 2018 Mar; 97(3):475-484. PubMed ID: 29353304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
    Chehal A; Taher A; Shamseddine A
    Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular origin and malignant transformation of Waldenström macroglobulinemia.
    Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF
    Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review.
    Chhabra S; Jain S; Fowler A; Sedov V; Neppalli AK; Schandl CA; Lazarchick J
    Ann Clin Lab Sci; 2017 Sep; 47(5):611-619. PubMed ID: 29066491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations.
    Maclachlan KH; Bagratuni T; Kastritis E; Ziccheddu B; Lu S; Yellapantula V; Famulare C; Argyropoulos K; Derkach A; Papaemmanuil E; Dogan A; Lesokhin A; Usmani SZ; Landgren CO; Palomba LM; Maura F; Dimopoulos MA
    Blood Adv; 2023 Mar; 7(6):971-981. PubMed ID: 36332058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia.
    Gayet M; Leymarie V; Derouault P; Guérin E; Vaidié J; Pascal V; Boulin M; Dmytruk N; Chauzeix J; Trimoreau F; Gachard N; Feuillard J; Rizzo D
    Cytometry B Clin Cytom; 2022 Jan; 102(1):62-69. PubMed ID: 33634586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
    Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
    Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mouse model of IgM
    Tompkins VS; Sompallae R; Rosean TR; Walsh S; Acevedo M; Kovalchuk AL; Han SS; Jing X; Holman C; Rehg JE; Herms S; Sunderland JS; Morse HC; Janz S
    Blood Cancer J; 2016 Nov; 6(11):e488. PubMed ID: 27813533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.